Aisling Capital as of June 30, 2015
Portfolio Holdings for Aisling Capital
Aisling Capital holds 18 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Esperion Therapeutics (ESPR) | 19.9 | $134M | 1.6M | 81.76 | |
| Zeltiq Aesthetics | 11.4 | $77M | 2.6M | 29.47 | |
| Cempra | 11.2 | $75M | 2.2M | 34.36 | |
| Loxo Oncology | 9.3 | $62M | 3.5M | 18.03 | |
| Chimerix (CMRX) | 7.0 | $47M | 1.0M | 46.20 | |
| T2 Biosystems | 6.1 | $41M | 2.5M | 16.23 | |
| Versartis | 5.2 | $35M | 2.3M | 15.22 | |
| Adma Biologics (ADMA) | 5.0 | $33M | 3.6M | 9.26 | |
| Sorrento Therapeutics Com New (SRNE) | 4.5 | $30M | 1.7M | 17.62 | |
| Agile Therapeutics | 3.8 | $26M | 3.0M | 8.59 | |
| Transenterix Com New | 3.7 | $25M | 8.3M | 3.00 | |
| Catalent | 3.1 | $21M | 716k | 29.33 | |
| Dermira | 2.9 | $19M | 1.1M | 17.55 | |
| Paratek Pharmaceuticals | 2.6 | $18M | 683k | 25.77 | |
| Pernix Therapeutics Holdings | 1.8 | $12M | 2.0M | 5.92 | |
| Intersect Ent | 1.5 | $10M | 350k | 28.63 | |
| Lombard Med (EVARF) | 0.6 | $3.9M | 886k | 4.40 | |
| Roka Bioscience | 0.4 | $2.7M | 1.0M | 2.60 |
